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Ocular pulse amplitude after trabeculectomy
Abstract Background: The ocular
pulse amplitude (OPA) is the differ-
ence between the minimum and
maximum values of the pulsatile
intraocular pressure (IOP) wave con-
tour. The OPA depends on ocular
perfusion and IOP, which are both
affected by a trabeculectomy (TE).
The aim of this study was to inves-
tigate how the OPA changes after TE
and whether an early change in OPA
can be used as a prognostic marker for
a successful long-term outcome.
Methods: Fourteen consecutive pa-
tients (26–84 years old) with medi-
cally uncontrolled primary open-angle
or pseudoexfoliation glaucoma were
included in the study. IOP and OPA
were measured with a dynamic con-
tour tonometer before and after TE on
days –1, +1, +7, +14, +21, +28, +42,
+56, +70, and +84. The OPA of the
contralateral eye was used to control
for variations in systemic haemody-
namics. TE was regarded as success-
ful if a persistent drop in IOP of at
least 20% without the use of IOP-
lowering treatment was achieved.
Data were analysed using receiver
operating characteristic curves,
Kaplan–Meier survival curves and
Mann–Whitney two-sample analysis.
Results: Five out of 14 TEs had an
entirely successful outcome. The
other 9 patients required additional
interventions such as suturolysis,
needling of subconjunctival scar tis-
sue and antimetabolite injections
during the 3-month period after the
TE. On the first day after surgery,
OPA decreased in 12 patients and
increased in 2 patients compared with
the preoperative measurements. In the
5 patients with a successful long-term
outcome, OPA dropped by 3.38±
1.79 mmHg (mean±SE), whereas the
initial OPA drop in those cases that
required additional interventions was
0.62+/−1.81 mmHg only (p<0.01).
IOP dropped by 13.10±2.14 mmHg in
the successful group and by 5.84±
2.51 mmHg in the unsuccessful group
(p=0.19). Kaplan-Meier estimates of
survival showed that patients with an
initial OPA drop of more than
2.0 mmHg had a significantly better
chance of an entirely uncomplicated
3-month outcome after TE than pa-
tients with an initial OPA drop of less
than 2.0 mmHg (log rank p<0.01).
Conclusion: This pilot study indi-
cates that an early drop in OPA of
more than 2.0 mmHg after TE may be
a good prognostic parameter for
successful long-term control of IOP.
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Introduction
Standardised evaluation of the bleb morphology after tra-
beculectomy (TE) has proven to be useful in identifying
cases of threatened bleb failure [13]. The management of
such patients requires intensive postsurgical follow-up.
Subsequent interventions such as suturolysis, subconjunc-
tival antimetabolite injections or bleb-needling procedures
are needed for long-term control of intraocular pressure
(IOP) if hypotensive medication is to be avoided. Howev-
er, failure of an individual bleb remains difficult to pre-
dict, and additional clinical parameters, especially in the
very early postoperative period, would be helpful in tai-
loring the intensity of the postoperative follow-up proto-
cols to individual needs. We hypothesised that the ocular
pulse amplitude (OPA), being the difference between the
minimum and maximum values of the ocular pulse wave
contour, represents such a parameter. The bulbus resem-
bles a pressurised shell that is subjected to pulsatile ex-
pansion generated by the rhythmic filling of intraocular
vessels. The corresponding fluctuation of the ocular vol-
ume leads to an oscillating variation in IOP that is coun-
terbalanced by the outer shell’s resistance to distension
[17]. These oscillations are mirrored in the ocular pulse
wave (Fig. 1) that can be recorded by continuously mea-
suring tonometers such as the dynamic contour tonometer
(Pascal, Swiss Microtechnology, Port, Switzerland) [10].
A successful TE wound creates an additional outflow fa-
cility for the aqueous that may compensate in part for the
increase in ocular volume during the cardiac systole. Hence,
a dampening of the OPA may be expected postoperatively.
The aim of this study was to investigate how the OPA
changes after TE and whether an initial drop in OPA has a
better predictive value than an initial drop in IOP for the
long-term success of trabeculectomy.
Methods
Fourteen consecutive patients with primary open-angle
glaucoma (POAG; n=7) or pseudoexfoliation glaucoma
(PEX; n=7) whose IOP was not adequately controlled
by medical therapy and who were undergoing TE for the
first time were prospectively included in the study. The
patients’ characteristics are given in Table 1. After the pa-
tients’ informed consent had been obtained the IOP and
the OPA were measured by dynamic contour tonometry
(DCT) on days –1, +1, +7, +14, +21, +28, +42, +56, +70
and +84 with respect to the day of surgery. The preop-
erative assessment included refraction, visual acuity, a
detailed slit-lamp examination and fundus examination.
Preoperative measurements were taken while the patients
were still under medical antihypertensive therapy. There
was no wash-out period before surgery. For each time point
the mean of four DCT measurements in the sitting position
was used to assess both IOP and OPA. To compensate for
diurnal OPA fluctuations as a result of fluctuating heart rate
and blood pressure, the changes in OPA of the contralateral
control eye were deducted from the changes found in the
operated eye. All patients were operated on by the same two
surgeons performing a standard TE with a fornix-based
conjunctival flap, a 3×5-mm scleral flap, a single-punch TE
and adjunctive use of mitomycin C (0.025% for 2 min).
Postoperative treatment consisted of intensive topical anti-
inflammatory treatment (0.1% dexamethasone phosphate
drops every 2 h and ointment at night). The outcome after
Fig. 1 Ocular pulse wave con-
tour as measured by dynamic
contour tonometry. The device
displays the diastolic readings as
intraocular pressure (IOP), and
the difference between the
means of systolic and diastolic
readings is furnished as ocular
pulse amplitude (OPA)
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TE was regarded as successful if a postoperative drop in
IOP of at least 20% at any time point was achieved
without the use of hypotensive treatment, laser suturolysis
or needling revisions [13].
Two different analytical approaches were performed:
To calculate the optimal cut-off value for the OPA and IOP
drop we plotted receiver operating characteristic (ROC)
curves. At these cut-off values we calculated the diagnostic
odds ratios. We then compared the areas under the ROC
curve of the two tests using the method proposed by
Hanley and McNeil to assess the predictive value of an
initial drop in OPA or IOP after surgery [7].
Second, we assessed the likelihood of an uncomplicated
outcome after trabeculectomy in a survival analysis where
we compared patients who showed a decrease in OPA of
at least 2.0 mmHg on the first postoperative day with
those experiencing a lower drop. Kaplan–Meier survival
curves were compared using the log rank test. Differences
in mean values between groups were tested using the
Mann–Whitney two-sample statistic. A p value of <0.05
was considered significant. Data are expressed as mean ±
standard deviation.
To estimate the reliability of the IOP and OPA mea-
surements obtained by DCTwe performed two analyses of
variance (ANOVAs) for the preoperative and first post-
operative measurements. For these analyses four mea-
surements for each patient were available at the two time
points. We used patient as the random factor, IOP and OPA
as the dependent variables. Based on the variance compo-
nents, we calculated the intraclass correlation coefficients
(ICCs) using the patient variance in the numerator and the
sum of residual and patient variance in the denominator.
From the variance component procedure, we used the var-
iance component of the residual error as the intraobserver
variability.
Results
Five out of the 14 patients had an entirely successful
outcome after TE with an IOP drop of at least 20% at any
time point after surgery. The other nine patients cases re-
quired additional interventions such as suturolysis (n=4),
needling of subconjunctival scar tissue (n=6) and antime-
tabolite injections (n=6) during the 3-month follow-up pe-
riod. Before surgery, baseline IOP and OPA did not differ
between the groups that subsequently experienced success-
ful or unsuccessful TE (IOP: 19.50±3.64 mmHg vs 24.47±
5.71 mmHg, p=0.10; OPA: 3.74±1.15 mmHg vs 4.00±
1.91 mmHg, p=0.75).
On the first day after surgery, OPA had dropped by 3.38±
1.79 mmHg in patients with a successful long-term out-
come, whereas the decrease in patients that eventually re-
quired additional interventions was only 0.62±1.81 mmHg
(p<0.01). The latter group comprises the only three patients
who experienced an increase in OPA instead of a decrease.
The IOP decreased on the first postoperative day in 13
out of 14 patients, the exception being one of the members
of the failure group. The initial drop in IOP was 13.10±
2.14 mmHg in cases with successful outcome and 5.84±
2.51 mmHg in cases with unsuccessful outcome respec-
tively (Fig. 2, p=0.19). In the patients with successful TE
the OPA decreased by 0.30±0.25 mmHg per 1-mmHg
drop in IOP, while the OPA in patients that required sub-
sequent interventions initially dropped by only 0.004±
0.49 mmHg per 1-mmHg drop in IOP (p=0.09). The ROC
Table 1 Characteristics of the
study group
Patient
number
Gender Age
(years)
Type of
glaucoma
Preoperative IOP
(mmHg)
Treatment before
surgery
Outcome
(1=failure)
1 F 70 PEX 21.5 Xalacom 1
2 F 80 PEX 33 Cosopt, Xalatan 1
3 F 74 PEX 16.8 Xalatan 0
4 M 60 POAG 21.3 Vistagan 0
5 F 84 POAG 21.3 Xalatan, Azopt 1
6 F 82 PEX 16.7 Lumigan 1
7 M 67 PEX 14.5 Xalacom, Alphagan 0
8 F 69 POAG 18.6 Travatan 1
9 F 61 PEX 22.8 Cosopt, Xalacom 0
10 F 74 POAG 25.9 Xalacom 1
11 M 38 POAG 22.1 Xalatan, Alphagan,
Cosopt
0
12 F 58 PEX 22.7 Travatan, Cosopt,
Alphagan
1
13 M 26 POAG 31.2 Timoptic, Alphagan,
Xalatan
1
14 M 73 POAG 29.4 Cosopt, Alphagan,
Xalatan
1
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curves indicated that a decrease in OPA of at least 2.0
mmHg and a drop in the IOP of more than 9 mmHg by the
time of measurement on the first postoperative day were
most predictive for treatment success. The area under the
ROC curve for an OPA drop was 0.91 (95% confidence
interval 0.70–1.00) and 0.78 (95%CI 0.50–1.00) for an IOP
drop, respectively (p=0.22). The corresponding odds ratios
were 14 (95%CI 1.0–208) and 8 (0.5–107), indicating that
an OPA drop was more accurate than an IOP drop as pre-
dictor of a successful outcome after TE.
Kaplan–Meier estimates of survival showed that patients
with an initial drop in OPA of more than 2.0 mmHg had a
significantly better chance of experiencing an entirely un-
complicated 3-month outcome, while patients with an ini-
tial decrease in OPA of less than 2.0 mmHg had a high
probability of failure requiring additional interventions (log
rank p=0.01, Fig. 3).
Assessment of the reliability of the IOP and OPA mea-
surements before and after TE showed preoperative and
postoperative ICCs for IOP of 0.85 and 0.95. The corre-
sponding ICCs for OPA were 0.5 and 0.79 respectively,
indicating a high reliability for IOP measurements and the
postoperative OPA measurements. The preoperative in-
traobserver variability for the OPAwas 1.6 mmHg, where-
as the variability of the first postoperative measurements
was 0.7 mmHg.
Discussion
This pilot study documents that the OPA goes down
after TE and that an OPA drop of more than 2.0 mmHg
on the first day after TE may be a prognostic indicator
of a favourable outcome without the need for additional
interventions.
Reports on OPA after TE are sparse: James investigated
the effect of TE on pulsatile ocular blood flow (POBF)
using a Langham OBF system, recording the OPA in 17
patients before and 3 and 6 months after TE [8]. In the
vertical position the drop in OPA (0.4 mmHg) became sig-
nificant only 6 months after surgery. The POBF, which is
based on a measurement of the OPA and recalculated into
a POBF value by the Langham OBF system, was found to
increase after TE. Similarly, Poinoosawmy et al. found an
increased POBF 2 weeks after TE using the same device
but did not report the OPA [15]. Both studies measured
OPA to investigate the long-term change in OBF, which is
recognised as an important haemodynamic factor for the
pathogenesis of glaucomatous optic neuropathy (for re-
view see [3]). However, calculations of the POBF that are
based on the OPA may become unreliable, as the calcula-
tions depend on the rigidity of the eyeball, which is al-
tered by the TE [20]. Our study differs from the studies
cited above in that we measured the OPA on the first day
after TE by DCT to investigate the role of the OPA as an
prognostic parameter for successful TE.
At this stage, we can only speculate about the underlying
mechanisms responsible for the more pronounced OPA
decrease in patients with successful TE than in those with
less successful TE requiring further interventions. An over-
all reduction in scleral rigidity following successful filter-
ing operation has been suggested as a potential cause of fall
Fig. 2 Mean IOP reduction
after TE. The outcome after TE
was regarded as successful if a
postoperative drop in IOP of at
least 20% was achieved at any
time point without the use of
any hypotensive treatment, laser
suturolysis or bleb-needling
procedures
Fig. 3 Kaplan–Meier survival analysis of TE with an OPA drop on
the first postoperative day of more or less than 2.0 mmHg compared
with the presurgical baseline OPA. Patients with a OPA drop of
more than 2.0 mmHg have an higher probability of a successful
outcome after TE (p=0.001)
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in OPA [20]. In addition to the above-mentioned change
in aqueous humour dynamics, the volume–pressure rela-
tion of the human eye provides another explanation: it is
known for several decades that the ocular shell’s resistance
to distension varies with the general IOP level and that the
OPA consecutively decreases as the IOP level is lowered
[19]. In this study, however, patients with an entirely suc-
cessful outcome after TE showed a higher drop in OPA per
1-mmHg drop in IOP than patients with an unsuccessful
outcome. Therefore we might speculate that the more pro-
nounced drop in OPA found in patients with an entirely
successful outcome after TE reflects a lower outflow resis-
tance in these cases.
Alternatively, the less favourable outcome of the TE in
cases with a higher OPA after surgery may be caused by
biological differences in wound healing. The higher OPA
reflects a higher amplitude in the pulsatile ocular wall ten-
sion, which may result in a different activation or mod-
ulation of the fibroblasts involved in the ocular wound
healing after TE [1, 5]. However, this aspect was beyond
the scope of this pilot study.
It is important to note that parameters such as axial
length [9, 14] and heart rate [6, 18] have not been con-
sidered in this study although an impact on the OPA has
been described. Reduction of axial length, as observed in
successful trabeculectomies [4], may result in an increased
OPA [14] and would therefore rather have hidden the
OPA-lowering effect found in this study in patients with
successful TE. To control for individual fluctuations of
cardiovascular parameters such as heart rate or blood pres-
sure, the changes in the OPA of the contralateral eye were
used as controls. Additional confounding effects may have
arisen from the hypotensive medication itself [16], as there
was no wash-out phase preoperatively. It has been sug-
gested that the effect of antiglaucoma medication on ocular
haemodynamics may also be due to a vascular effect un-
related to the decrease in IOP [2]. However, in our study
neither patients with a successful TE nor those with an
unsuccessful TE received any pressure-lowering drugs to
the operated eye during the 3-month study period after TE.
Direct comparisons between studies on ocular pulse
waves must be made cautiously, as the accuracy and reli-
ability of the measuring tonometer are crucial [12]. DCT
has been shown to compare favourably to Goldmann ap-
planation tonometry with respect to inter- and intraobserver
variability (0.65 mmHg and 0.44 mmHg respectively) and
independence from corneal curvature and thickness [10].
Probably even more important for the evaluation of ocu-
lar haemodynamics is the finding that DCT reproduces
the manometrically controlled IOP level with high fidel-
ity [11].
The low probability of a successful outcome after TE in
patients with a drop in OPA of less than 2.0 mmHg on the
first day after surgery is an important finding. The OPA
represents a parameter which can be easily measured in
clinical routine and which might prove useful at an early
stage after TE in those patients who are in need of frequent
follow-up appointments and possibly additional interven-
tions. However, this was a pilot study in a small number of
patients, possibly confounded by different types of glau-
coma and other yet unknown factors that could influence
OPA measurements. Until the findings of this pilot study
are confirmed by larger, well-controlled studies, patients
should be monitored closely after TE irrespective of an
early drop in OPA.
References
1. Ajubi NE, Klein-Nulend J, Nijweide
PJ, Vrijheid-Lammers T, Alblas MJ,
Burger EH (1996) Pulsating fluid flow
increases prostaglandin production by
cultured chicken osteocytes—a cyto-
skeleton-dependent process. Biochem
Biophys Res Commun 225:62–68
2. Cantor LB (2001) The effect of trabe-
culectomy on ocular hemodynamics.
Trans Am Ophthalmol Soc 99:241–252
3. Flammer J, Orgul S, Costa VP, Orzalesi
N, Krieglstein GK, Serra LM, Renard
JP, Stefansson E (2002) The impact of
ocular blood flow in glaucoma. Prog
Retin Eye Res 21:359–393
4. Francis BA, Wang M, Lei H, Du LT,
Minckler DS, Green RL, Roland C
(2005) Changes in axial length follow-
ing trabeculectomy and glaucoma
drainage device surgery. Br J Ophthal-
mol 89:17–20
5. Fujikura H, Seko Y, Tokoro T,
Mochizuki M, Shimokawa H (2002)
Involvement of mechanical stretch in
the gelatinolytic activity of the fibrous
sclera of chicks, in vitro. Jpn J
Ophthalmol 46:24–30
6. Gekkieva M, Orgul S, Gherghel D,
Gugleta K, Prunte C, Flammer J (2001)
The influence of sex difference in
measurements with the Langham Ocu-
lar Blood Flow System. Jpn J
Ophthalmol 45:528–532
7. Hanley JA, McNeil BJ (1983) A
method of comparing the areas under
receiver operating characteristic curves
derived from the same cases. Radiology
148:839–843
8. James CB (1994) Effect of trabecu-
lectomy on pulsatile ocular blood flow.
Br J Ophthalmol 78:818–822
9. James CB, Trew DR, Clark K, Smith
SE (1991) Factors influencing the oc-
ular pulse–axial length. Graefes Arch
Clin Exp Ophthalmol 229:341–344
10. Kaufmann C, Bachmann LM, Thiel
MA (2004) Comparison of dynamic
contour tonometry with Goldmann ap-
planation tonometry. Invest Ophthalmol
Vis Sci 45:3118–3121
50
11. Kniestedt C, Nee M, Stamper RL
(2004) Dynamic contour tonometry: a
comparative study on human cadaver
eyes. Arch Ophthalmol 122:1287–1293
12. Krakau CET (1992) Calculation of the
pulsatile ocular blood flow. Invest
Ophthalmol Vis Sci 33:2754–2756
13. Marquardt D, Lieb WE, Grehn F
(2004) Intensified postoperative care
versus conventional follow-up: a retro-
spective long-term analysis of 177
trabeculectomies. Graefes Arch Clin
Exp Ophthalmol 242:106–113
14. Perkins ES (1981) The ocular pulse.
Curr Eye Res 1:19–23
15. Poinoosawmy D, Indar A, Bunce C,
Garway-Heath DF, Hitchings RA
(2002) Effect of treatment by medicine
or surgery on intraocular pressure and
pulsatile ocular blood flow in normal-
pressure glaucoma. Graefes Arch Clin
Exp Ophthalmol 240:721–726
16. Schmidt KG, Dick B, von Ruckmann
A, Pillunat LE (1997) Ocular pulse
amplitude and local carbonic anhydrase
inhibition. Ophthalmologe 94:659–664
17. Silver DM, Geyer O (2000) Pressure-
volume relation for the living human
eye. Curr Eye Res 20:115–120
18. Trew DR, James CB, Thomas SH,
Sutton R, Smith SE (1991) Factors
influencing the ocular pulse–the heart
rate. Graefes Arch Clin Exp Ophthal-
mol 229:553–556
19. Wegner W (1930) Neue Ergebnisse
ueber die pulsatorischen Schwankun-
gen des menschlichen Bulbus und
seiner Huellen. Arch Augenheilkd
102:1–32
20. Yang YC, Hulbert MF (1995) Effect of
trabeculectomy on pulsatile ocular
blood flow. Br J Ophthalmol 79:507–
508
51
